`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`FRESENIUS KABI USA, LLC,
`Petitioner,
`
`Vv.
`
`NOVO NORDISKA/S,
`Patent Owner.
`
`Case IPR2022-00657
`Patent 8,114,833
`
`PATENT OWNER’S POWER OF ATTORNEY
`
`
`
`PATENT OWNER’S POWER OF ATTORNEY
`
`IPR2022-00657
`Patent 8,114,833
`
`Patent Owner, Novo Nordisk A/S, hereby appoints the following as its
`
`attorneys to transact all business in the United States Patent & Trademark Office
`
`associated with the above-captioned inter partes review:
`
`Jeffrey J. Oelke having a postal, email, and hand-delivery addressof:
`
`Jeffrey J. Oelke, Reg. No. 37,409
`Fenwick & West LLP
`902 Broadway,Suite 14
`New York, New York 10010
`Telephone:(212) 430-2600
`joelke@fenwick.com
`
`Ryan P. Johnson (pro hac vice to be sought), having a postal, email, and
`
`hand-delivery addressof:
`
`Ryan P. Johnson
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, New York 10010
`Telephone: (212) 430-2600
`
`ryan.johnson@fenwick.com
`
`Laura T. Moran (pro hac vice to be sought), having a postal, email,.and
`
`hand-delivery addressof:
`
`Laura T. Moran
`Fenwick & West LLP
`902 Broadway, Suite 14
`New York, New York 10010
`Telephone: (212) 430-2600
`laura.moran@fenwick.com
`
`
`
`IPR2022-00657
`Patent 8,114,833
`
`and all other practitioners working in conjunction with the aforementioned
`
`attorneys.
`
`The individual signing below hasthe authority to execute this document on
`
`behalf of Novo Nordisk A/S.
`
`
`
`[SIGNATURE]
`
`JACOB eSAR PETERS
`
`Y[BY]
`
`CoRR Uic€
`;
`
`.
`
`PRESSDELFT
`[TITLE]
`
`
`
`2 MAACH le2e
`[DATE]
`
`
`
`IPR2022-00657
`Patent 8,114,833
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. §§ 42.6, I hereby certify that the foregoing Patent
`
`Owner’s Power of Attorney document was served on March 24, 2022, by filing this
`
`document through the Patent Trial and Appeal Board End to End System, as well as
`
`delivering a copy via electronic mail upon the following attorneys of record for the
`
`Petitioner:
`
`Linnea Cipriano
`Daryl Wiesen
`lcipriano@goodwinlaw.com
`dwiesen@goodwinlaw.com
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Jeffrey J. Oelke/
`Jeffrey J. Oelke (Reg. No. 37,409)
`
`Counsel for Novo Nordisk A/S
`
`
`
`3
`
`
`
`Date: March 24, 2022
`
`
`
`
`
`
`
`
`
`
`